Vitreofoveal Traction Associated With Pilocarpine for Presbyopia
Vuity (pilocarpine HCL ophthalmic 1.25%) was approved for the treatment of presbyopia in October 2021. Previous case series have reported the presence of vitreofoveal traction and retinal detachment following pilocarpine administration, but this was not reported in the recent randomized control tria...
Description complète
Détails bibliographiques
| Publié dans: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 53(2022), 7 vom: 06. Juli, Seite 410-411
|
|---|
| Auteur principal: |
Amarikwa, Linus
(Auteur) |
|---|
| Autres auteurs: |
Michalak, Suzanne M,
Caul, Susan,
Mruthyunjaya, Prithvi,
Rahimy, Ehsan |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2022
|
|---|
| Accès à la collection: | Ophthalmic surgery, lasers & imaging retina
|
|---|
| Sujets: | Case Reports
Journal Article
Pilocarpine
01MI4Q9DI3 |
|---|